OXT and migraine disorder: Future studies using longer-lasting or brain-penetrant antagonists are needed to further clarify oxytocin's role in migraine susceptibility.<h4>Trial registration information</h4>DRKS - Deutsches Register Klinischer Studien: DRKS00033341.